Immunity for Health: Vaccines & Immunotherapy

16–17 Oct 2024 | RodeBol Events

Ghent University - PROVAXS

Academic institution

www.provaxs.comMerelbeke, Belgium

About

Provaxs is Ghent University’s Business Development Center and industrial liaison for innovation in animal health.

We combine scientific expertise, knowledge and know-how on animal health with an entrepreneurial organisation of scientists and experienced tech-transfer professionals. Not only that, but thanks to the Industrial Research Fund of Ghent University we have access to proof-of-concept funding, open for collaboration with industry.

We are receptive to all types of collaborations and partnerships:

  •  out-licensing and development of our UGent-technologies towards the final product

  • research collaboration on a single project, either bilateral or in a research consortium

  • strategic partnerships with a specific focus/topic.

 All our collaborations and partnerships are supported by a professional business development/tech-transfer team and are based on solid tailor-made agreements on confidentiality, ownership, and exploitation of results.

RESEARCH AND DEVELOPMENT

Preclinical researchCell and Gene therapyVaccine developmentmRNA vaccinesVaccine platformsVaccine adjuvantsVaccine delivery systemsViral vectorsStem cellsTranslational researchInfectious diseases modelling and epidemiologyDiagnostics

INVESTMENT AND BUSINESS DEVELOPMENT

Business development and partnerships

THERAPEUTIC AREAS

Infectious diseasesOncologyImmunology

HEALTH SECTOR

Animal health

DIGITAL HEALTH AND TECHNOLOGY

Nanotechnology

INTELLECTUAL PROPERTY AND LEGAL SERVICES

Intellectual property

Representatives

Sven ARNOUTS

Business Development Manager

Ghent University - PROVAXS